Bacopa's Research History, From Brahmi to Memory Trials
Bacopa carries a memory reputation older than its human trials. This history runs from brahmi in Ayurvedic writing to a 1982 rat study, the 2001 trials, and a 2022 trial in children, and says plainly what those trials did and did not show.
The history of bacopa is a story of a memory reputation that is older than its human trials. Bacopa monnieri has long been called brahmi in Ayurvedic practice, and a 1982 rat study describes it as a reputed nerve tonic in Ayurvedic literature. The sources checked here test that reputation in rats in 1982, move to human trials in 2001, and reach children in 2022. The record is real, but it is narrower than the reputation. ## A name and a reputation before any trial According to PubMed, a 1998 paper classifies bacopa in Ayurveda as Medhyarasayana, a group of nervine tonics used "to promote mental health and improve memory and intellect" ([DOI](https://doi.org/10.1016/S0944-7113(98)80001-9)). A 2022 review describes the plant as "Brahmi" or "Water Hyssop" and says it has been used in Ayurveda for centuries as a brain tonic and memory enhancer ([DOI](https://doi.org/10.1007/s00253-022-11834-0)). Older records use another botanical name. A 1967 paper titled "Some behavioural effects of an active fraction from Herpestis monniera, Linn. (Brahmi)" is indexed in PubMed without an abstract, so this post does not report its results ([PubMed](https://pubmed.ncbi.nlm.nih.gov/6065425/)). The sources checked do not explain why the plant is called brahmi, and they do not name the ancient text that first lists it. ## Animal work leads the record In 1982, Singh and Dhawan gave rats an alcoholic extract at 40 mg/kg by mouth for three or more days. The treated rats showed better acquisition and improved retention in a shock-motivated brightness discrimination task, and their responses extinguished more slowly. The authors wrote that their findings were "in conformity with the Ayurvedic claims" ([DOI](https://doi.org/10.1016/0378-8741(82)90044-7)). By 2001, the human question was still open. Stough and colleagues wrote that bacopa extracts had been "reported to exert cognitive enhancing effects in animals," and that "the effects on human cognition are inconclusive" ([DOI](https://doi.org/10.1007/s002130100815)). For another Ayurvedic herb, see the [turmeric history](/blog/history/history-of-turmeric-and-curcumin-from-ayurveda-to-isolation). ## Two 2001 papers gave different answers Both papers appeared in 2001, and they tested different things. Nathan and colleagues gave 300 mg of a bacopa extract as a single dose to 18 people, with 20 on placebo, and tested before dosing and two hours after. According to PubMed, "No significant changes were found on any of the tests." The authors limited their conclusion to "at least for the dose administered" ([DOI](https://doi.org/10.1002/hup.306)). Stough and colleagues gave 300 mg of extract over 12 weeks in a double-blind, placebo-controlled trial, testing at baseline and at 5 and 12 weeks. Compared with placebo, the bacopa group improved on speed of visual information processing, on learning rate and memory consolidation measured by the AVLT, and on state anxiety. The largest effects appeared at 12 weeks ([DOI](https://doi.org/10.1007/s002130100815)). A single dose and 12 weeks of dosing are different tests, so the two papers should not be read as one result. ## Trials of standardized extracts, 2012 to 2022 Downey and colleagues gave 320 mg and 640 mg of CDRI 08 to 24 healthy volunteers in a crossover design. The authors reported that the 320 mg dose improved performance at the first, second, and fourth repetition after dosing on the Cognitive Demand Battery, and that the treatments had no effect on cardiovascular activity or on ratings of stress and fatigue ([DOI](https://doi.org/10.1002/ptr.4864)). Benson and colleagues ran a similar acute crossover with 17 healthy volunteers at 320 mg and 640 mg. They reported positive cognitive changes at one and two hours on the Letter Search and Stroop tasks, some mood effects, and reduced cortisol levels in saliva. They called for replication in a larger sample ([DOI](https://doi.org/10.1002/ptr.5029)). Kean and colleagues ran a 14-week trial of CDRI 08 in boys aged 6 to 14 with inattention and hyperactivity. Of 112 recruited, 93 datasets were analyzed. The authors reported no significant behavioral differences between groups. They reported improvements over placebo in cognitive flexibility (p = .01), executive functioning (p = .04), interpersonal problems (p = .02) and a sleep routine measure (p = .04), and fewer errors in the CDRI 08 group (p = .04). Reaction time speed rose in the placebo group (p = .04). They called for further study ([DOI](https://doi.org/10.1002/ptr.7372)). These trials measured different outcomes, so they do not add up to one result. ## Why the trials lean on standardized extracts Pase and colleagues reviewed six randomized, controlled trials, all run over 12 weeks. Three different extracts were used, at 300 to 450 mg of extract a day. Across the trials, bacopa improved performance on 9 of 17 memory free recall tests, and the review found "little evidence of enhancement" in other cognitive domains ([DOI](https://doi.org/10.1089/acm.2011.0367)). The authors called for work on varied doses and across different extracts. The chemistry explains part of that need. Murthy calls bacosides, a group of dammarane-type triterpenoid saponins, "the principal chemical ingredients identified and described" from the plant. The same review notes that bacoside content varies across regions of the plant and with season and genotype ([DOI](https://doi.org/10.1007/s00253-022-11834-0)). A 1998 rat study describes a standardized extract with bacoside A content of 25.5 ± 0.8% ([DOI](https://doi.org/10.1016/S0944-7113(98)80001-9)). A 2024 systematic review lists bacosides A and B among the active compounds it names ([DOI](https://doi.org/10.3390/antiox13040393)). For the extract used in the 2012, 2013 and 2022 trials above, see the [CDRI 08 research article](/research/synapsa-cdri-08-bacopa-monnieri-cognitive-enhancement). For the plant itself, see the [bacopa ingredient page](/ingredients/bacopa-monnieri). ## What the sources do not settle - The origin of the name brahmi, and the ancient text that first lists it. The Charaka Samhita passage often cited for brahmi was not checked against a primary source, so this post leaves it out. - Early memory studies beyond the 1982 rat paper. This post's PubMed checks for 1960 to 1999 did not turn up another controlled memory study with an abstract. - Who paid for the trials. The abstracts name the extract as CDRI 08, with KeenMind in the 2012 and 2013 abstracts, but none names a sponsor. - Sample size. The trials that report numbers here range from 17 to 93 participants, and their authors ask for replication. - The 2024 review's broad statements about disease outcomes. They rest on studies this post did not check one by one, so they are not repeated here. ## Bottom line The reputation is older than the evidence. Two results carry most of the weight here. In 1982, rats given an extract showed better acquisition in a shock-motivated task, and in 2012 a review found improved performance on 9 of 17 memory free recall tests across six trials. Both are narrow. Three of the human trials checked here were acute studies, and all of them used different extracts, doses or outcomes, so the record supports a narrow reading: a traditional memory belief that trials have tested in part. For the wider reference, see the [brain health guide](/health/brain-health-focus-complete-guide). The oldest study with a reported result measured avoidance responses in rats. The newest measured error-making and reaction time in boys. Which of those measures a future trial should repeat is the question the sources leave open. ## Next reads - [Bacopa ingredient page](/ingredients/bacopa-monnieri): the plant record, for the ingredient-level reference. - [CDRI 08 research article](/research/synapsa-cdri-08-bacopa-monnieri-cognitive-enhancement): the extract used in the 2012, 2013 and 2022 trials above. - [Turmeric history](/blog/history/history-of-turmeric-and-curcumin-from-ayurveda-to-isolation): another Ayurvedic herb, traced from tradition to isolation. ### Related reading - [the ginkgo origin story from temple trees to leaf extract](/blog/history/history-of-ginkgo-from-temple-trees-to-leaf-extract)